A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
第一著者: | Sorno, Rubina Haque |
---|---|
その他の著者: | Khair, Nishat Zareen |
フォーマット: | 学位論文 |
言語: | English |
出版事項: |
Brac University
2024
|
主題: | |
オンライン・アクセス: | http://hdl.handle.net/10361/23842 |
類似資料
-
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
著者:: Flora, Sanzida Alam
出版事項: (2024) -
A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
著者:: Khan, Muidul Hasan
出版事項: (2024) -
In silico modelling and structural dynamics of PSY1R kinase domain and its interaction with SERK1 kinase
著者:: Ruhee, Noshin Nawer
出版事項: (2022) -
Arresting tumor cell proliferation and inhibition of AKT pathway via the use of multikinase inhibitor sorafenib forthe treatment of glioblastoma
著者:: Raju, Md. Ismail
出版事項: (2022) -
A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
著者:: Ratu, Tabassum
出版事項: (2024)